Epclusa
Payments companies reported to CMS as associated with Epclusa. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Epclusa, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Epclusa
These are the largest totals companies reported as associated with Epclusa. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Kathleen Scholz | Pittsburgh, PA | Family | $201,142.97 |
| Susan Julius | Baton Rouge, LA | Addiction Medicine (Family Medicine) | $191,617.12 |
| Anthony Martinez | Buffalo, NY | Internal Medicine | $163,315.53 |
| Gia Landry | Baton Rouge, LA | Gastroenterology (Internal Medicine) | $143,753.79 |
| Tejas Joshi | Huntington, WV | Hepatology | $121,088.98 |
| Kweilynn Greene | Pittsburgh, PA | Family | $105,661.14 |
| Paul Chan | Orlando, FL | Primary Care | $104,039.32 |
| Phyllis Losikoff | Providence, RI | Pediatrics | $91,103.23 |
| Apurva Modi | Rockville, MD | Gastroenterology (Internal Medicine) | $88,395.81 |
| Christian Ramers | San Diego, CA | Internal Medicine | $87,504.79 |
Prescribed Epclusa?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.